Company Filing History:
2 out of 5 
1 out of 3 
1 out of 1 Years Active: 2016-2018
Title: Pidder Jansen-Dürr: Innovator in Monoclonal Antibodies
Introduction
Pidder Jansen-Dürr is a notable inventor based in Innsbruck, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for the treatment and understanding of human papillomavirus (HPV).
Latest Patents
Jansen-Dürr holds a patent for Anti-HPV E7 antibodies. These monoclonal antibodies are capable of specifically recognizing an epitope of the C-terminal or the N-terminal region of a HPV E7 protein. This innovation represents a crucial advancement in the fight against HPV-related diseases.
Career Highlights
Throughout his career, Jansen-Dürr has been associated with esteemed organizations such as Österreichische Akademie der Wissenschaften and Austria Wirtschaftsservice Gesellschaft mbH. His work in these institutions has allowed him to further his research and contribute to the scientific community.
Collaborations
Some of his notable coworkers include Werner Zwerschke and Haymo Pircher. Their collaborative efforts have likely enhanced the impact of Jansen-Dürr's research and innovations.
Conclusion
Pidder Jansen-Dürr's contributions to the field of monoclonal antibodies and his patent for Anti-HPV E7 antibodies highlight his role as an important figure in biotechnology. His work continues to influence the understanding and treatment of HPV-related conditions.